AA

Anitha Akula

Active Director Designated Partner DIN 09177031
DIN 09177031 First appointment May 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Anitha Akula

Data last updated:

Anitha Akula is a Designated Partner at Rupag Pharma Llp (since 2021). The company operates in Pharma.

DIN 09177031
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rupag Pharma Llp AAX-0515
Designated Partner17 May 20212021Active

Board colleagues of Anitha Akula

NameDINCompanyDesignation
Alugubelly Latha Prasanna03603067Rupag Pharma LlpDesignated Partner
Alugubelly Upender Reddy03603064Rupag Pharma LlpDesignated Partner
Gnanendra Thirupathi06615703Rupag Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Rupag Pharma Llp
Premium access

Shareholding and investment profile for Anitha Akula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anitha Akula

Anitha Akula currently holds 1 directorship: Rupag Pharma Llp (Designated Partner, since 17 May 2021).

Anitha Akula was first appointed on 17 May 2021 as Designated Partner at Rupag Pharma Llp.

The current boards of Anitha Akula's companies include Alugubelly Latha Prasanna (Rupag Pharma Llp), Alugubelly Upender Reddy (Rupag Pharma Llp), Gnanendra Thirupathi (Rupag Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available